VBI Vaccines Inc. (VBIV)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 18.63M |
| Enterprise value | 47.99M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 1.17 |
| Price/book (mrq) | 2.48 |
| Enterprise value/revenue | 5.53 |
| Enterprise value/EBITDA | -0.69 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.89 |
| 52-week change 3 | -78.55% |
| S&P500 52-week change 3 | 26.36% |
| 52-week high 3 | 3.4700 |
| 52-week low 3 | 0.4500 |
| 50-day moving average 3 | 0.6130 |
| 200-day moving average 3 | 0.7153 |
Share statistics
| Avg vol (3-month) 3 | 431.7k |
| Avg vol (10-day) 3 | 119.24k |
| Shares outstanding 5 | 28.68M |
| Implied shares outstanding 6 | 28.68M |
| Float 8 | 26.5M |
| % held by insiders 1 | 6.77% |
| % held by institutions 1 | 13.03% |
| Shares short (30 Apr 2024) 4 | 372.81k |
| Short ratio (30 Apr 2024) 4 | 0.36 |
| Short % of float (30 Apr 2024) 4 | 1.57% |
| Short % of shares outstanding (30 Apr 2024) 4 | 1.30% |
| Shares short (prior month 28 Mar 2024) 4 | 289.12k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 28 Dec 2012 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:30 |
| Last split date 3 | 12 Apr 2023 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -1,449.47% |
Management effectiveness
| Return on assets (ttm) | -28.57% |
| Return on equity (ttm) | -258.99% |
Income statement
| Revenue (ttm) | 8.68M |
| Revenue per share (ttm) | 0.56 |
| Quarterly revenue growth (yoy) | 191.10% |
| Gross profit (ttm) | N/A |
| EBITDA | -53.32M |
| Net income avi to common (ttm) | -93.84M |
| Diluted EPS (ttm) | -6.0300 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 23.68M |
| Total cash per share (mrq) | 0.83 |
| Total debt (mrq) | 53.04M |
| Total debt/equity (mrq) | 704.66% |
| Current ratio (mrq) | 0.48 |
| Book value per share (mrq) | 0.31 |
Cash flow statement
| Operating cash flow (ttm) | -60.88M |
| Levered free cash flow (ttm) | -39.41M |
© 2024 Yahoo. All rights reserved.